tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MRSN Stock Latest News

Buy Rating for Mersana Therapeutics: Promising Potential in Post-Topo TNBC with Emi-Le ADC
RatingsBuy Rating for Mersana Therapeutics: Promising Potential in Post-Topo TNBC with Emi-Le ADC
2d ago
MRSN
Mersana Therapeutics Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
Mersana Therapeutics Faces Nasdaq Non-Compliance Notice
1M ago
8K
MRSN
Mersana Therapeutics’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Mersana Therapeutics’ Earnings Call Highlights Progress and Challenges
1M ago
MRSN
Mersana Therapeutics Positioned Favorably with Promising Developments and Strategic Adjustments Supporting Buy Rating
PremiumRatings
Mersana Therapeutics Positioned Favorably with Promising Developments and Strategic Adjustments Supporting Buy Rating
2M ago
MRSN
Mersana Therapeutics price target adjusted to $36 at Truist after reverse split
PremiumThe Fly
Mersana Therapeutics price target adjusted to $36 at Truist after reverse split
2M ago
MRSN
Mersana Therapeutics Faces Financial Strain Amid U.S. Tariff Uncertainties
PremiumCompany AnnouncementsMersana Therapeutics Faces Financial Strain Amid U.S. Tariff Uncertainties
2M ago
MRSN
Mersana Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Mersana Therapeutics Reports Q2 2025 Financial Results
2M ago
MRSN
Mersana Therapeutics price target adjusted to $17 at BTIG after reverse split
Premium
The Fly
Mersana Therapeutics price target adjusted to $17 at BTIG after reverse split
2M ago
MRSN
Promising Progress and Strategic Focus Drive Buy Rating for Mersana Therapeutics
PremiumRatings
Promising Progress and Strategic Focus Drive Buy Rating for Mersana Therapeutics
2M ago
MRSN
Mersana Therapeutics reports Q2 EPS ($4.87), consensus ($4.25)
PremiumThe Fly
Mersana Therapeutics reports Q2 EPS ($4.87), consensus ($4.25)
2M ago
MRSN
MRSN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
MRSN Upcoming Earnings Report: What to Expect?
2M ago
MRSN
Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested
3M ago
AGRI
AIHS
Mersana Therapeutics trading halted, news pending
PremiumThe FlyMersana Therapeutics trading halted, news pending
3M ago
MRSN
Mersana Therapeutics Announces Reverse Stock Split
Premium
Company Announcements
Mersana Therapeutics Announces Reverse Stock Split
3M ago
8K
MRSN
Mersana Therapeutics announces 1-for-25 reverse stock split
Premium
The Fly
Mersana Therapeutics announces 1-for-25 reverse stock split
3M ago
MRSN
Mersana Therapeutics’ XMT-1660 Study: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Mersana Therapeutics’ XMT-1660 Study: A Potential Game-Changer in Cancer Treatment
3M ago
MRSN
Mersana Therapeutics Advances HER2-Targeted Cancer Therapy with XMT-2056 Study
PremiumCompany Announcements
Mersana Therapeutics Advances HER2-Targeted Cancer Therapy with XMT-2056 Study
3M ago
MRSN
Mersana Therapeutics Settles Debt with Oxford Finance
PremiumCompany Announcements
Mersana Therapeutics Settles Debt with Oxford Finance
3M ago
8K
MRSN
Mersana Therapeutics Approves Key Proposals at Annual Meeting
PremiumCompany Announcements
Mersana Therapeutics Approves Key Proposals at Annual Meeting
4M ago
8K
MRSN
Promising Developments in Mersana Therapeutics’ Emi-Le Program Bolster Positive Outlook for TNBC Treatment
PremiumRatingsPromising Developments in Mersana Therapeutics’ Emi-Le Program Bolster Positive Outlook for TNBC Treatment
4M ago
MRSN
Mersana Therapeutics Reports Positive Phase 1 Trial Results
Premium
Company Announcements
Mersana Therapeutics Reports Positive Phase 1 Trial Results
4M ago
8K
MRSN
Mersana Therapeutics reports additional interim Phase 1 data for Emi-Le
Premium
The Fly
Mersana Therapeutics reports additional interim Phase 1 data for Emi-Le
4M ago
MRSN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >